| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/18/1990 | EP0377657A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 07/18/1990 | EP0377583A1 Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 07/18/1990 | EP0377579A1 Recombinant fibroblast growth factors |
| 07/18/1990 | CN1043941A C63-amide derivatives of 34-de(acetyl-glucosaminyl)-34-deoxy-teicoplanins |
| 07/18/1990 | CN1043939A Process for preparing 63-carboxyamides of teicoplanin antibiotics |
| 07/18/1990 | CN1043875A Novel 1 l-2 receptor-specific human immunoglobins |
| 07/18/1990 | CN1043874A Cpf peptide compositions and uses |
| 07/17/1990 | US4942230 Process for preparing synthetic virginiamycin M1 analogs |
| 07/17/1990 | US4942153 Spray of water-soluble animal collagen, water |
| 07/17/1990 | US4942125 Cloning vectors for hepatitis, polypeptides, antigens, analysis of antibodies |
| 07/17/1990 | US4942123 ppRB110 -phosphoprotein the retinoblastoma susceptibility gene product |
| 07/17/1990 | US4942122 Kits for diagnosis of aids and developing a prognosis |
| 07/17/1990 | US4942035 Polypeptides and noncrosslinked linear, branched or graft block copolymers with hydrophobic biodegradable part and hydrophilic part |
| 07/17/1990 | US4942031 Compositions containing LYCD and other topically active medicinal ingredients |
| 07/17/1990 | CA2007886A1 Human insulin-like growth factor analogs with reduced binding to 28 k igf binding proteins and their production in yeast |
| 07/17/1990 | CA2007364A1 Gene sequences encoding modified residues situated in the protease domain of tpa |
| 07/17/1990 | CA2006700A1 Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| 07/17/1990 | CA1271900A1 Toxin conjugates |
| 07/17/1990 | CA1271899A1 Grf analogs |
| 07/17/1990 | CA1271898A1 Grf analogs |
| 07/17/1990 | CA1271718A1 Fibrinolytic enzyme derivatives |
| 07/17/1990 | CA1271715A1 Monoclonal antibody |
| 07/15/1990 | WO1990007928A1 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 07/15/1990 | CA2026580A1 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 07/13/1990 | CA2025018A1 Compositions containing thymopentin for topical treatment of skin disorders |
| 07/13/1990 | CA2007545A1 Production method for protein-containing composition |
| 07/13/1990 | CA2007238A1 Anti-tryptase antibody and composition for treatment of aids using the same |
| 07/12/1990 | WO1990008528A1 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/12/1990 | WO1990007792A1 Method of making high density solder bumps and a substrate socket for high density solder bumps |
| 07/12/1990 | WO1990007579A1 Tumour necrosis factor muteins |
| 07/12/1990 | WO1990007578A1 Recombinant fish hormone proteins |
| 07/12/1990 | WO1990007577A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs |
| 07/12/1990 | WO1990007572A1 HUMAN DNase |
| 07/12/1990 | WO1990007571A1 Method of modifying cellular differentiation and function and compositions therefor |
| 07/12/1990 | WO1990007524A1 Monoclonal antibody against protein c |
| 07/12/1990 | WO1990007523A1 Medicament comprising cyclolinopeptide a |
| 07/12/1990 | WO1990007522A1 Human insulin analogues |
| 07/12/1990 | WO1990007521A1 Renin inhibitors containing c-terminal dihydroxy amides |
| 07/12/1990 | WO1990007518A1 Differentiation antigen, nda4, associated with the receptor for b cell growth factor |
| 07/12/1990 | WO1990007517A1 Receptor transcription-repression activity compositions and methods |
| 07/12/1990 | WO1990007469A1 Pulmonary administration of pharmaceutically active substances |
| 07/12/1990 | WO1990007341A1 Purified ciliary neurotrophic factor |
| 07/12/1990 | WO1990007340A1 Anti-hiv agent |
| 07/12/1990 | WO1990007336A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 07/12/1990 | WO1990007321A2 Lymphocyte receptor homing sequences and their uses |
| 07/12/1990 | WO1990006323A3 Chimeric proteins incorporating a metal binding protein |
| 07/12/1990 | WO1990005528A3 Anti-thrombotic steroids |
| 07/12/1990 | WO1990005520A3 Tissue culture antiviral processes and compositions |
| 07/12/1990 | WO1990003394A3 New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines |
| 07/12/1990 | DE3843534A1 Neue tnf-polypeptide New tnf-polypeptide |
| 07/12/1990 | CA2045131A1 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/12/1990 | CA2007521A1 Factor inhibiting the complement, characterization and applications |
| 07/11/1990 | WO1990007931A1 Method of promoting hair growth by applying a blood platelet extract |
| 07/11/1990 | EP0377540A1 Recombinant fish hormone proteins |
| 07/11/1990 | EP0377527A1 Process for preparing fibres from human skin collagen, the fibres so prepared and compositions containing them |
| 07/11/1990 | EP0377489A2 Purified C5a receptor from human polymorphonuclear leukocytes |
| 07/11/1990 | EP0377477A1 Process for microencapsulation |
| 07/11/1990 | EP0377303A1 Non-A, non-B hepatitis virus genome RNA, cDNA and virus antigen protein |
| 07/11/1990 | EP0377139A1 N-substituted acylamino acid compounds, process for their production and their use |
| 07/11/1990 | EP0377114A1 Method for preparing pertussis toxin toxoid |
| 07/11/1990 | EP0377044A1 Protective agent for radiation hazard |
| 07/11/1990 | EP0376973A1 Monoclonal antibodies reactive with cytomegalovirus glycoprotein a |
| 07/11/1990 | CN1043719A Process for preparation of human insulin analogues |
| 07/11/1990 | CN1043705A Process for preparing optically active 2-oxoimidazolidine derivatives |
| 07/11/1990 | CN1043631A Composition for controlled release of polypeptides |
| 07/11/1990 | CA2045144A1 Wound healing agents |
| 07/11/1990 | CA2004819A1 Immune cell proliferation inhibitors |
| 07/10/1990 | US4940816 Acylated cyanamide compounds |
| 07/10/1990 | US4940782 Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore |
| 07/10/1990 | US4940665 Method for granulation of enzyme |
| 07/10/1990 | US4940662 Low-molecular weight peptide mixture and method of producing same |
| 07/10/1990 | CA2007026A1 Methods and compositions for treatment of angiogenic diseases |
| 07/10/1990 | CA1271600A1 Growth hormone-releasing peptides and method of treating mammals therewith |
| 07/10/1990 | CA1271599A1 Grf analogs |
| 07/10/1990 | CA1271598A1 Pharmacologically active 5-oxo-1 imidazoldine acetamide compounds |
| 07/10/1990 | CA1271597A1 Biologically-active xanthine derivatives |
| 07/10/1990 | CA1271596A1 Hypotensive peptides, their preparation and their use |
| 07/10/1990 | CA1271360A1 Enteral nutritional hypoallergenic formula |
| 07/09/1990 | EP0221173A4 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof. |
| 07/09/1990 | CA2007305A1 Differentiation antigen, nda4, associated with the receptor for b cell growth factor |
| 07/09/1990 | CA2007083A1 Pharmaceutical use of trypstatin |
| 07/07/1990 | CA2045516A1 Generation and selection of novel dna-binding proteins and polypeptides |
| 07/06/1990 | CA2007124A1 Motilin-like polyptide and use thereof |
| 07/05/1990 | DE3841736A1 Ancrod-proteine, ihre herstellung und verwendung Ancrod proteins, their production and use |
| 07/04/1990 | EP0376931A1 Process for making collagen membranous materials for medical use |
| 07/04/1990 | EP0376785A2 Cloning and expression of transforming growth factor beta 2 |
| 07/04/1990 | EP0376770A1 Use of human immunoglobulins G or their Fc fragments thereof as a medicament preparatory to the administration of monoclonal antibodies to man |
| 07/04/1990 | EP0376746A2 Gene family of tumor-associated antigens |
| 07/04/1990 | EP0376491A1 Polypeptide with cell-spreading activity |
| 07/04/1990 | EP0376251A2 A novel thrombomodulin-like glycoprotein obtainable from urine |
| 07/04/1990 | EP0376189A2 Kit or reagent for assaying the cellular integrity of blood platelets and pharmaceutical compositions containing a PKA inhibitor |
| 07/04/1990 | EP0376176A2 Bispecific monoclonal antibody, its production and use |
| 07/04/1990 | EP0376156A2 New insulin derivatives, process for their preparation, their use and pharmaceutical compositions containing them |
| 07/04/1990 | EP0376041A2 C63-Amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanins |
| 07/04/1990 | EP0376040A2 N-phosphinyl di-and tripeptides as renin inhibitors |
| 07/04/1990 | EP0376012A2 Renin inhibitors |
| 07/04/1990 | EP0375885A1 Aqueous elcatonin solution composition |
| 07/04/1990 | EP0375852A1 Biologically active whey protein composition, a method for producing it and use of the composition |
| 07/04/1990 | EP0375767A1 Peptides with protective properties with regard to a pathogenic virus of the hiv type in sensitive cells. |
| 07/04/1990 | EP0375736A1 Nucleic acid fragments encoding mannose binding fragments of human mannose binding protein |